Melanie Matheu is the founder of Prellis Biologics. Prellis Biologics has raised $50M in total funding. Latest round: Series C. Based in Irvine, California.
Melanie Matheu, PhD, founded Prellis Biologics in October 2016 to develop high-resolution laser-based 3D bioprinting. She served as the company's founder and CEO until 2022, transitioning to lead scientific endeavors. In 2024, she co-founded Lyric Bio Inc., leveraging the Prellis system.
Full founder directory · Investor directory · Company funding database · Fundraising library